LAWSUITS NEWS & LEGAL INFORMATION
$688M Settlement Awarded in Vytorin Class Action Lawsuit
This is a settlement for the Vytorin Marketing lawsuit.
New York, NY: A $688 million settlement has been approved by a federal judge effectively ending claims that Merck & Co. Inc. and its subsidiary Schering-Plough Corp. concealed test results on the efficacy of their anti-cholesterol drug Vytorin.
US District Court Judge Dennis M. Cavanaugh signed the orders this week, approving the $688 million settlement Merck and Schering-Plough offered in February just prior to the class action' trial date. Merck and Schering-Plough porposed making the settlement to avoid going to trial scheduled to begin in March. Neither defendant has admitted any wrongdoing.
The massive settlement will end claims against the companies for the vast majority of the class, save for 187 plaintiffs who opted out, according to the order.
Published on Oct-2-13
US District Court Judge Dennis M. Cavanaugh signed the orders this week, approving the $688 million settlement Merck and Schering-Plough offered in February just prior to the class action' trial date. Merck and Schering-Plough porposed making the settlement to avoid going to trial scheduled to begin in March. Neither defendant has admitted any wrongdoing.
The massive settlement will end claims against the companies for the vast majority of the class, save for 187 plaintiffs who opted out, according to the order.
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please fill in our form.Published on Oct-2-13
READ MORE Consumer Fraud Settlements and Legal News
READ MORE Drugs/Medical Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News
READER COMMENTS
David. Micheletti
on
Not only did the drug not work but it caused health issues as a result.
I'm faced with health issues related to this.
Bonnie Brown
on
Glenn and Georgia Moore
on